This announcement informs that Jianfan Biotechnology Group Co., Ltd. will resume the conversion of its convertible bonds (code: 123117) on June 1, 2026, after a temporary suspension from May 25 to May 29, 2026, due to the implementation of the 2025 equity distribution plan. Bondholders are advised to take note of this change.
Summary generated by AI · Always verify with source document
The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.